Abstract
Background
Alzheimer's disease (AD) is characterized by early and region-specific declines in cerebral glucose metabolism. Ketone bodies are produced by the body during glucose deprivat READ MORE http://www.nutritionandmetabolism.com/content/6/1/31
The ketogenic diet has been in clinical use for over 80 years, primarily for the symptomatic treatment of epilepsy. A recent clinical study has raised the possibility that exposure to the ketogenic di READ MORE http://www.pubmedcentral.nih.gov/articlerender.fcgi...
